Pyxis Oncology, Inc. (PYXS) NASDAQ

2.55

+0.3(+13.33%)

Updated at October 03 03:14PM

Currency In USD

Valuation

Market Cap91.18M
Enterprise Value91.9M
P/E Ratio-1.64
PEG Ratio2.57
Price/Sales Ratio25.42
Price/Book Ratio1.8
Enterprise/Revenue26.82
Enterprise/EBITDA-1.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-15.48
Operating Margin-17.11

Management Effectiveness

Return On Assets-0.78
Return On Equity-0.83

Income Statement

Revenue16.15M
Revenue/Share0.1
Gross Profit15.67M
EBITDA-65.51M
Net Income-77.33M
Diluted EPS-1.32

Balance Sheet

Total Cash88.94M
Total Cash/Share1.44
Total Debt19.46M
Total Debt/Equity0.22
Current Ratio5.65
Book Value Per Share1.42

Price History

52-Week Change-27.35
52-Week High5.39
52-Week Low0.83
Moving Average 50 Days1.56
Moving Average 200 Days1.33

Statistics

Average Volume570,361
Shares Outstanding62.02M
% Held by Institutions44.26

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A